KYORIN Pharmaceutical Co., Ltd. (TYO:4569)

KYORIN Pharmaceutical Revenue

KYORIN Pharmaceutical had revenue of 28.50B JPY in the quarter ending September 30, 2025, with 6.67% growth. This brings the company's revenue in the last twelve months to 133.68B, up 11.65% year-over-year. In the fiscal year ending March 31, 2025, KYORIN Pharmaceutical had annual revenue of 130.09B with 8.83% growth.

• Revenue (ttm): 133.68B
• Revenue Growth: +11.65%
• P/S Ratio: 0.69
• Revenue / Employee: 66.91M
• Employees: 1,998
• Market Cap: 92.27B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	130.09B	10.56B	8.83%
Mar 31, 2024	119.53B	6.26B	5.53%
Mar 31, 2023	113.27B	7.74B	7.33%
Mar 31, 2022	105.53B	2.63B	2.56%
Mar 31, 2021	102.90B	-7.08B	-6.44%